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Background: Cornelia de Lange syndrome (CdLS) is a dominantly inherited disorder characterized by facial
dysmorphism, growth and cognitive impairment, limb malformations and multiple organ involvement. Mutations in
NIPBL gene account for about 60% of patients with CdLS. This gene encodes a key regulator of the Cohesin
complex, which controls sister chromatid segregation during both mitosis and meiosis. Turner syndrome (TS) results
from the partial or complete absence of one of the X chromosomes, usually associated with congenital
lymphedema, short stature, and gonadal dysgenesis.
Case presentation: Here we report a four-year-old female with CdLS due to a frameshift mutation in the NIPBL
gene (c.1445_1448delGAGA), who also had a tissue-specific mosaic 45,X/46,XX karyotype. The patient showed a
severe form of CdLS with craniofacial dysmorphism, pre- and post-natal growth delay, cardiovascular abnormalities,
hirsutism and severe psychomotor retardation with behavioural problems. She also presented with minor clinical
features consistent with TS, including peripheral lymphedema and webbed neck. The NIPBL mutation was present
in the two tissues analysed from different embryonic origins (peripheral blood lymphocytes and oral mucosa
epithelial cells). However, the percentage of cells with monosomy X was low and variable in tissues. These findings
indicate that, ontogenically, the NIPBL mutation may have appeared before the mosaic monosomy X.
Conclusions: The coexistence in several patients of these two rare disorders raises the issue of whether there is
indeed a cause-effect association. The detailed clinical descriptions indicate predominant CdLS phenotype, although
additional TS manifestations may appear in adolescence.
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reproduction in any medium, provided the orimpairment, limb malformations, hirsutism and the in-
volvement of other organ systems with variable expres-
sivity [1]. Prevalence estimates range from 1:62,000 to
1:45,000 live births [2]. To date, mutations in three
genes have been identified in ~65% of clinically well-
defined CdLS cases, namely: NIPBL on chromosome
5p13 (60%), SMC1A on chromosome Xp11 and SMC3
on chromosome 10q25 (5%) [3-6]. These three genes
encode regulatory or structural components of the
highly conserved Cohesin complex, which participates
in chromosome segregation, DNA repair mechanisms,
gene expression and chromosome conformation [7].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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disorder, usually associated with short stature, gonadal
dysgenesis, cardiovascular abnormalities, hearing loss,
neck webbing and lymphedema; although a number
of organ systems and tissues may also be affected to
a lesser or greater extent [8]. TS affects about one in
2000 live born females and results from complete or
partial absence of one of the X chromosomes, fre-
quently accompanied by cell-line mosaicism, which
may also be tissue-specific [9,10].
Chromosomal rearrangements in individuals with
CdLS have been reported over the years, involving 1–5,
7–14, 17, 18, 21 and X chromosomes [11]. To date, only
four patients with CdLS have been reported to have sex
chromosome anomalies: one male with 45,X/46,XY mo-
saicism [12], one female with 45,X karyotype [13] and
two females with mosaic 45,X/46,XX karyotypes [14,15].
We report a female with CdLS, with an identified muta-
tion in the NIPBL gene, and TS due to a mosaic 45,X/46,
XX karyotype. We present a detailed phenotype descrip-
tion focusing on the typical clinical features of CdLS and
TS. Furthermore, we compare the phenotype of our pa-
tient to other reported cases with similar karyotype and
an unknown or different genotype. Finally, we examine
the significance of a possible association of both
syndromes.
Case presentation
The patient is the first child of a healthy and unre-
lated 35-year-old father and a 37-year-old mother.
There was no family history of congenital defects. She
has a healthy younger brother. The girl was born at
35 weeks gestation by caesarean section due to pla-
cental insufficiency. Birth weight was 1.350 kg, length
43 cm and head circumference 25 cm (all below the
3rd centile for gestational age) (Table 1). Apgar score
was 7 in the first minute and 9 at five minutes. Cra-
niofacial dysmorphism included: microbrachycephaly,
bitemporal narrowing distance, synophrys, arched eye-
brows, long and irregularly placed eyelashes,
depressed nasal bridge, anteverted nares, long and flat
philtrum, thin upper lip, downslanting corners of the
mouth, micrognathia, high arched and vaulted palate,
low-set and posteriorly rotated ears, low posterior
hairline, short and webbed neck and hirsutism
(Figure 1A and B, Table 1). She had small hands and
feet, lymphedema of the feet (resolved at two months
of age), bilateral clinodactyly of the fifth finger, pro-
ximally placed thumbs, single palmar crease and hip
dislocation (Figure 1B, D and E, Table 1). Additional
neonatal findings included mild hypertonia, lack of
the sucking reflex, congenital bilateral glaucoma, ret-
inopathy, atrial and ventricular septal defect (ASD -
VSD) and mild pulmonary stenosis (PS) that did notrequire surgery. At two years of age gastroesophageal
reflux disease (GERD) was suspected although it
could not be confirmed. More detailed clinical de-
scription of the patient is provided in Table 1.
At the age of 3 years and 6 months (Figure 1C-E)
her weight was 9.1 kg, height 81 cm and head cir-
cumference 41 cm (≤ 50th centile on CdLS growth
charts).Physical examination showed broad chest with
widely spaced nipples, short sternum, bilateral cubitus
valgus, limited elbow extension, small and hypoplastic
nails and myopia. Developmental milestones were se-
verely delayed. She was able to sit unsupported, but
not to stand or walk. Speech was absent but she
could follow simple instructions. The patient had
autistic-like features with episodes of aggression and
self-injurious behaviour. Mild bilateral sensorineural
hearing loss was detected by auditory brainstem re-
sponse (ABR). She had delayed bone age (Figure 1D)
(Table 1). Biochemical, endocrine and metabolic stud-
ies were normal, except for high serum TG (triglycer-
ide) levels (232 mg/dL; normal value range for TG
levels is < 98 mg/dL). Thyroid function tests (T3, T4,
TSH) and celiac screen (IgA-TTG and IgA-EmA anti-
bodies) were also normal.
Methods and results
Molecular analysis
Blood samples and buccal smears were obtained after
written informed consent, and genomic DNA was iso-
lated from peripheral blood lymphocytes and oral mu-
cosa epithelial cells by standard protocols. The entire
coding region and flanking intron sequences of NIPBL
(exons 2–47) were screened for mutations by bidirec-
tional sequencing. The NIPBL reference sequence
used was NM_133433. Parental genotypes were
screened to assess whether the variant was de novo or
inherited.
NIPBL mutational screening showed a de novo muta-
tion in exon 9 (c.1445_1448delGAGA), which predicts a
truncated protein p.R482NfsX20 (Figures 2A and B). To
test whether the patient carries the NIPBL mutation in
mosaic state, molecular analyses were performed on two
tissues of different embryonic origins: peripheral blood
lymphocytes (mesoderm) and epithelial cells from oral
mucosa (ectoderm). The mutation-related peaks were
similar in both tissues, ruling out widespread mosaicism
(Figure 2A).
Cytogenetic analysis
Conventional cytogenetic analysis of metaphase chromo-
somes prepared from cultured peripheral blood lympho-
cytes was performed according to standard procedures
using the GTG banding technique. Karyotype was 45,X/46,
XX, with 24% cells containing only one X chromosome
Table 1 Clinical data for patients with typical features of CdLS and TS
Clinical findings CdLS and 45,X/46,XX
mosaicism [14]






TS CdLS TS CdLS TS CdLS
Birth parameters and growth
Birth weight< 10th centile - + - + - -
Length at birth<10th centile - + - + N/A N/A
Growth: Short stature + + + + + +
Craniofacial features
Eye Synophrys - + - + - +
Arched eyebrows - + - + - +
Long eyelashes - + - + - -
Nose Depressed nasal bridge - + - + - -
Anteverted nares - + - + - -
Philtrum Long - + - + - +
Prominent - + - + - -
Smooth - + - + - +
Mouth Thin upper lip - + - + - +
Down-slanting corners - + - + - -
Widely-spaced teeth - + - - - +
Micrognathia + + + + + +
Ear Low-set + + + + - -
Posteriorly rotated - + - + - -
Neck Low posterior hairline + + + + - -
Short neck + + + + + +
Webbed neck + - + - - -
Skull Microbrachycephaly - + - + - +
Bitemporal narrowing distance - + - + - +
Skull asymmetry with right-sided flattening - - - - - +
Neurology and cognitive profile
Neurological involvement: Hypertonia - + - + N/A N/A
Cognitive: Mental retardation N/A N/A - + - +
Verbal and motor developmental delay
Speech delay + + + + + +
Language delay - + - + - +
Developmental delay - + - + - +
Musculoskeletal system
Small hands and/or feet - + - + - +
5th finger clinodactyly - + - + N/A N/A
Syndactyly 3rd-4th fingers - - - - - +
Proximally placed thumb - + - + - +
Single palmar crease - - - + N/A N/A
Wide Space 1st 2nd toes - - - - - +
Bilateral cubitus valgus - - + - N/A N/A
Limited elbow extension - + - + N/A N/A
Hip dislocation - - + + N/A N/A
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Table 1 Clinical data for patients with typical features of CdLS and TS (Continued)
Short sternum - - + - N/A N/A
Scoliosis - - - - + +
Bone age retardation - - + - N/A N/A
Broad chest with widely-spaced nipples + - + - + -
Ophthalmologic findings
Glaucoma - - + + N/A N/A
Retinopathy N/A N/A - + N/A N/A
Myopia N/A N/A + + N/A N/A
ENT manifestations
Sensorineural hearing loss N/A N/A + + N/A N/A
Skin and nails
Lymphedema of the feet - - + - - -
Hirsutism - + - + - -
Cutis marmorata - - - + N/A N/A
Small and hypoplastic nails + - + - - -
Hyperconvexed nails - - - - + -
Cardiac system
ASD, VSD and PS - - - + - -
Tetralogy of Fallot - - - - - +
Gastrointestinal system
GERD + + + + + +
Gastrointestinal malrotation - - - - - +
Constipation - - - + - +
Feeding problems - - + + + +
Poor sucking and swallowing reflexes + - + - N/A N/A
(+) Present; (−) Not present; N/A: Not available; OFC: Occipito-Frontal Circumference; ENT: Ear-Nose-Throat; ASV: Atrial Septal Defect; VSD: Ventricular Septal
Defect; PS: Pulmonary Stenosis; GERD: Gastroesophageal Reflux Disease.
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examined and both were normal.
Fluorescence in situ hybridization (FISH) analysis
FISH analyses were performed on cultured peripheral
blood lymphocytes and oral mucosa epithelial cells of
the patient. Interphase nuclei were hybridized withFigure 1 Phenotype of the patient. (A) Frontal view of the patient in the
age of 2 years and 10 months; and (C) at 3 years. (D) Roentgenogram of th
patient at the age of 3 years. Note typical CdLS facial features seen in our p
depressed nasal bridge and anteverted nares, long and flat philtrum, thin u
rotated ears and microbrachycephaly (A-C). Several mild musculoskeletal an
clinodactyly of the fifth finger and proximally placed thumb (D).commercial CEP X Spectrum Orange/Y Spectrum
Green Direct Labeled Fluorescent DNA Probes
(Abbott Molecular) according to the manufacturer’s
instructions. For each analysis, a minimum of 500 or
100 interphase nuclei from blood lymphocytes or oral
mucosa epithelial cells were scored, respectively.
FISH analyses confirmed the presence of 45,X/46,XXfirst week of life. (B) Frontal view and right hand of the patient at the
e left hand at the age of 3 years and 6 months and (E) left foot of the
atient included synophrys, arched eyebrows, long eyelashes,
pper lip, downslanting corners of the mouth, low set and posteriorly
omalies were noted including small hands and feet (D and E),
Figure 2 (A) Pedigree of the affected family and partial electropherograms of exon 9 of the NIPBL gene. White symbols indicate
unaffected individuals, whereas black symbol indicate the affected individual. The sequencing analysis performed on genomic DNA from the
patient peripheral blood lymphocytes (v) and oral mucosa epithelial cells (vi) shows similar heights of the peaks of the allele carrying the
c.1445_1448delGAGA mutation in both tissues. Wild-type electropherograms identified in the normal parents are also indicated (i-iv). (B)
Schematic model of the NIPBL gene. Sequence features of human NIPBL protein previously reported are indicated [23,30] . The open reading
frame of NIPBL gene is marked in light grey. The exon 9 of the NIPBL gene is highlighted in red.
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monosomy X in peripheral blood lymphocytes and
buccal smears, respectively (Figures 3C-E).
Discussion
Here we report a patient with CdLS and a NIPBL frame-
shift mutation (c.1445_1448delGAGA deletion, p.
Arg482AsnfsX20), who also had mosaic TS. Clinical diag-
nosis of CdLS was suspected from the typical craniofacialfeatures, hirsutism, pre- and post-natal growth retard-
ation, congenital heart defects and delayed psychomotor
development with specific behavioural problems (Table 1).
Following the scoring system for severity proposed by
Kline et al. [2007] [16], she has a severe CdLS phenotype
despite the mild anomalies of the upper limbs. In fact, the
same NIPBL mutation was previously identified in another
female with CdLS from Portugal, who had a similar
phenotype [17]. Interestingly, our patient also showed
Figure 3 GTG-banded and FISH images from lymphocytes and buccal epithelial cells. Panels (A-B) show karyotypes of peripheral blood
lymphocytes demonstrating the 45,X/46,XX mosaicism. Panels (C-E) show FISH analysis using CEP X Spectrum Orange/Y Spectrum Green Direct
Labelled Fluorescent DNA probes from Abbott Molecular within of interphase nuclei of lymphocytes (C-D) and buccal epithelial cells (E). (C) and
(E) show FISH interphase cells with one copy of the X chromosome (arrow). (D) and (E) show the presence of two copies of the X chromosomes
(double arrows). Only representative cells with different karyotypes are shown here.
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period [10] (Table 1), suggesting the diagnosis of TS,
which was subsequently confirmed by cytogenetic
analysis.
Ophthalmologic findings have been reported in a high
percentage of CdLS and TS patients. However, the con-
genital bilateral glaucoma diagnosed in our case has
been described in only three patients with CdLS, and in
three other patients with mosaic TS [18-20].
Congenital heart defects (CHD) are common both in
TS (17-45%) [10,21] and in CdLS (13-70%) [16,22]. Our
case has CHD that are common in CdLS (ASD, VSD
and PS) but rarely seen in TS (<0.5%) [16,21-23].
To date, only four patients with chromosomal rearran-
gements involving sex chromosomes have been reported
in CdLS [12-15]. Only two of those cases had detailed
clinical description and mosaic TS karyotype and could
be compared to our patient [14,15] (Table 1).
The genotype of the first case, reported by Klosovskiĭ
et al. in 1968, is still unknown [14]. Like our patient she
was diagnosed during childhood, and she also showed
similar TS features and severe CdLS phenotype (Table 1).
More recently, Hoppman-Chaney et al. reported a fe-
male patient with a novel multi-exon deletion of the
SMC1A gene, who showed an unusual, severe phenotype
of CdLS and a mosaic monosomy X (35% of peripheral
blood lymphocytes) [15] (Table 1). Remarkably, her clin-
ical findings related to mosaic TS were fewer and milder
than in our patient. She had broad chest with wide-setnipples and hyperconvexed fingernails [15] (Table 1). This
could be explained by the highly variable phenotypic ex-
pression of mosaic TS individuals [24]. Moreover, she also
presented with atypical facial features for CdLS, such as
prominent metopic suture, sparse hair, deep-set eyes and
long and narrow earlobes [15]. She also showed severe
typical features of classic CdLS, rarely seen in affected
females with SMC1A mutations [3,15,23,25] (Table 1).
This discrepancy could be due to the nature of her muta-
tion, which causes severe protein dysfunction, similar to
that caused by truncating mutations in the NIPBL gene
[3,15,23,25,26].
Molecular genetic analysis in our patient identified a
de novo heterozygous frameshift mutation in exon 9 of
the NIPBL gene (c.1445_1448delGAGA), resulting in a
predicted stop codon and truncation of the translational
product (p.R482NfsX20). Six additional truncating muta-
tions have been found inside exon 9 [17,27], which is the
second longest coding exon in NIPBL gene (627 base
pairs). They are located within the N-terminal half of the
protein, which is apparently only conserved in verte-
brates and where most of the truncating mutations have
been identified (~70% vs 42%C-terminal half ). These
data suggest this domain is important, although it has
not yet been associated with any specific function [23].
FISH analyses of tissues from different germ layers
revealed a low level of mosaicism for monosomy X.
However, the NIPBL mutation was identified in all the
tissues analyzed, ruling out somatic mosaicism. These
Wierzba et al. BMC Medical Genetics 2012, 13:43 Page 7 of 8
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appeared earlier than the aneuploidy for the X
chromosome.
Surprisingly, frameshift mutations in exon 9 of NIPBL
have also been identified in some gastrointestinal can-
cers associated with chromosomal instability and aneu-
ploidy [7,28,29]. It has been proposed that these
mutations could alter chromosome segregation, the ca-
nonical role for the Cohesin complex, leading to
chromosome imbalance with chromosome loss or gain
[25,28]. This hypothesis may provide an explanation for
the aneuploidy in our case, since a common cause of
mosaicism is nondisjunction in an early postzygotic mi-
totic division. Hence, we suggest that the mutation in
NIPBL could be the cause of the monosomy of the X
chromosome. Moreover, this hypothesis would explain
the numerous reports of individuals clinically diagnosed
with CdLS who also carried a chromosomal abnormality
[11,15]. Further experiments will be needed to confirm
this association.
Conclusions
Here, we report a patient with CdLS due to a muta-
tion in the NIPBL gene and mosaic TS. This patient
showed the classical phenotype of CdLS, although
without limb reduction. She was also clinically diag-
nosed with TS because of two typical recognizable fea-
tures of the syndrome: the peripheral lymphedema and
the webbed neck. Molecular characterization showed
that the NIPBL mutation was present in all the tissues
analyzed from different embryonic origins (mesoderm
and ectoderm), while FISH analyses revealed that the
mosaicism for the monosomy of the X chromosome
was tissue specific. These findings indicate that, onto-
genically, the NIPBL mutation appeared before the
monosomy X. Moreover, the recent identification of
frameshift mutations in exon 9 of the NIPBL gene in
colon cancer cells associated with chromosome aneu-
ploidy suggests that the NIPBL mutation could con-
tribute to the loss of the X chromosome [28].
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